Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 4Recruiting 3Withdrawn 2Active not recruiting 2Unknown 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Genitourinary 1

Conditions

Hypoxia 2Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × pimonidazole × Clear all
NCT03262311 2019-12-23

Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours

Institute of Cancer Research, United Kingdom

Phase NA Completed
21 enrolled
Tumor-Agnostic

Neoplasms

NCT01248637 2018-07-30

Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole

University Health Network, Toronto

Completed
200 enrolled
Gastrointestinal

Hypoxia, Pancreatic Neoplasms

NCT01992042 2017-10-26

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
33 enrolled
Genitourinary

Prostatic Neoplasms

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed
14 enrolled
Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡